Literature DB >> 20140009

Premetastatic milieu explained by TLR4 agonist-mediated homeostatic inflammation.

Yoshiro Maru1.   

Abstract

Accumulating evidence suggests that Toll-like receptor 4 (TLR4), a sensor for danger signals, is expressed not only in immune cells, but also in resident epithelial cells, and appears to participate in tissue homeostasis. To explain the premetastatic microenvironment created by the newly discovered endogenous TLR4 ligands, I propose a hypothesis of homeostatic inflammation that includes the classical danger hypothesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140009      PMCID: PMC4001895          DOI: 10.1038/cmi.2009.113

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  55 in total

Review 1.  Plasticity of CD4+ T cell lineage differentiation.

Authors:  Liang Zhou; Mark M W Chong; Dan R Littman
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

2.  Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

Authors:  Purevdorj B Olkhanud; Dolgor Baatar; Monica Bodogai; Fran Hakim; Ronald Gress; Robin L Anderson; Jie Deng; Mai Xu; Susanne Briest; Arya Biragyn
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

3.  Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.

Authors:  Cesar A Corzo; Matthew J Cotter; Pingyan Cheng; Fendong Cheng; Sergei Kusmartsev; Eduardo Sotomayor; Tapan Padhya; Thomas V McCaffrey; Judith C McCaffrey; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

4.  WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.

Authors:  Don X Nguyen; Anne C Chiang; Xiang H-F Zhang; Juliet Y Kim; Mark G Kris; Marc Ladanyi; William L Gerald; Joan Massagué
Journal:  Cell       Date:  2009-07-02       Impact factor: 41.582

5.  G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models.

Authors:  Farbod Shojaei; Xiumin Wu; Xueping Qu; Marcin Kowanetz; Lanlan Yu; Martha Tan; Y Gloria Meng; Napoleone Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-03       Impact factor: 11.205

Review 6.  Epithelial-mesenchymal transition and cell cooperativity in metastasis.

Authors:  Takanori Tsuji; Soichiro Ibaragi; Guo-fu Hu
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

7.  Identification of a bone marrow-derived epithelial-like population capable of repopulating injured mouse airway epithelium.

Authors:  Amy P Wong; Armand Keating; Wei-Yang Lu; Pascal Duchesneau; Xinghua Wang; Adrian Sacher; Jim Hu; Thomas K Waddell
Journal:  J Clin Invest       Date:  2009-01-26       Impact factor: 14.808

8.  Latent bone metastasis in breast cancer tied to Src-dependent survival signals.

Authors:  Xiang H-F Zhang; Qiongqing Wang; William Gerald; Clifford A Hudis; Larry Norton; Marcel Smid; John A Foekens; Joan Massagué
Journal:  Cancer Cell       Date:  2009-07-07       Impact factor: 31.743

9.  Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota.

Authors:  Christopher S Reigstad; Gunnel Ostergren Lundén; Jenny Felin; Fredrik Bäckhed
Journal:  PLoS One       Date:  2009-06-09       Impact factor: 3.240

10.  CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation.

Authors:  Cedric Auffray; Darin K Fogg; Emilie Narni-Mancinelli; Brigitte Senechal; Celine Trouillet; Noah Saederup; Julia Leemput; Karine Bigot; Laura Campisi; Marc Abitbol; Thierry Molina; Israel Charo; David A Hume; Ana Cumano; Gregoire Lauvau; Frederic Geissmann
Journal:  J Exp Med       Date:  2009-03-09       Impact factor: 14.307

View more
  1 in total

Review 1.  Stimuli-induced organ-specific injury enhancement of organotropic metastasis in a spatiotemporal regulation.

Authors:  Dongwei Gao; Sha Li
Journal:  Pathol Oncol Res       Date:  2013-12-20       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.